InflaRx (IFRX) Shares Outstanding (2017 - 2025)

InflaRx has disclosed Shares Outstanding across 8 years of filings, most recently posting $84.2 million for Q4 2025.

• Shares Outstanding for Q4 2025 came in at $84.2 million, up 32.68% year-over-year; the trailing twelve-month figure through Dec 2025 was $84.2 million (up 32.68% YoY), and the FY2025 annual result was $84.2 million, up 32.68% from the prior year.
• Shares Outstanding came in at $84.2 million for Q4 2025 at InflaRx, up from $63.4 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $84.2 million in Q4 2025 to a low of $45.6 million in Q4 2022.
• The 5-year median for Shares Outstanding is $63.4 million (2023), against an average of $61.4 million.
• Across the five-year window, Shares Outstanding surged 50.25% in 2021 and dropped 9.81% in 2022, its largest moves.
• InflaRx's Shares Outstanding stood at $50.6 million in 2021, then slipped by 9.81% to $45.6 million in 2022, then soared by 38.91% to $63.4 million in 2023, then climbed by 0.11% to $63.4 million in 2024, then jumped by 32.68% to $84.2 million in 2025.
• The last three Shares Outstanding figures came in at $84.2 million (Q4 2025), $63.4 million (Q4 2024), and $63.4 million (Q4 2023), per Business Quant data.